Chlamydia pneumoniae is present in the dental plaque of periodontitis patients and stimulates an inflammatory response in gingival epithelial cells. by Almeida-da-Silva, Cássio Luiz Coutinho et al.
UC Merced
UC Merced Previously Published Works
Title
Chlamydia pneumoniae is present in the dental plaque of periodontitis patients and 
stimulates an inflammatory response in gingival epithelial cells.
Permalink
https://escholarship.org/uc/item/0610v2k7
Journal
Microbial cell (Graz, Austria), 6(4)
ISSN
2311-2638
Authors
Almeida-da-Silva, Cássio Luiz Coutinho
Alpagot, Tamer
Zhu, Ye
et al.
Publication Date
2019-03-11
DOI
10.15698/mic2019.04.674
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
  
 
 
OPEN ACCESS | www.microbialcell.com 197 Microbial Cell | APRIL 2019 | Vol. 6 No. 4 
www.microbialcell.com 
Research Article 
ABSTRACT  Chlamydia pneumoniae is an airborne, Gram-negative, obligate 
intracellular bacterium which causes human respiratory infections and has 
been associated with atherosclerosis. Because individuals with periodontitis 
are at greater risk for atherosclerosis as well as respiratory infections, we in-
vestigated the role of C. pneumoniae in inflammation and periodontal dis-
ease. We found that C. pneumoniae was more frequently found in subgingival 
dental plaque obtained from periodontally diseased sites of the mouth versus 
healthy sites. The known periodontal pathogens, Porphyromonas gingivalis 
and Aggregatibacter actinomycetemcomitans, were also found in the plaque.  
In addition, C. pneumoniae could efficiently invade human gingival epithelial 
cells (GECs) in vitro, causing translocation of NF-κB to the nucleus along with 
increased secretion of mature IL-1β cytokine. Supernatants collected from C. 
pneumoniae-infected GECs showed increased activation of caspase-1 protein, 
which was significantly reduced when nlrp3 gene expression was silenced 
using shRNA lentiviral vectors. Our results demonstrate that C. pneumoniae 
was found in higher levels in periodontitis patients compared to control pa-
tients. Additionally, C. pneumoniae could infect GECs, leading to inflammation 
caused by activation of NF-κB and the NLRP3 inflammasome. We propose that 
the presence of C. pneumoniae in subgingival dental plaque may contribute to 
periodontal disease and could be used as a potential risk indicator of perio-
dontal disease. 
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INTRODUCTION 
Periodontitis is the most common oral inflammatory dis-
ease [1]. It involves inflammation and destruction of the 
attachment apparatus of the teeth (i.e., gingiva, periodon-
tal ligament, root cementum and alveolar bone). Periodon-
titis begins with an infection of the gingival tissue by etio-
logic agents. Bacterial invasion of the gingiva elicits a host 
immune response which begins with inflammation of the 
gingiva, progressing to destruction of deep periodontal 
tissues and loss of alveolar bone. Even though over 600 
species of bacteria are present in the human oral microbi-
ome, only about ten have been identified as putative path-
ogens causing periodontal disease [2]. These putative 
pathogens are mainly Gram-negative anaerobic bacteria 
and include Aggregatibacter actinomycetemcomitans, Por-
phyromonas gingivalis, Porphyromonas intermedia, Bac-
teroides forsythus, Campylobacter rectus, Eubacterium 
nodatum, Porphyromonas micros, Staphylococcus interme-
dius and Treponema spp. [3]. Of these ten species, 
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A. actinomycetemcomitans, P. gingivalis and B. forsythus 
are most commonly associated with periodontitis [4-6]. 
Chlamydiae are obligate, intracellular bacteria that 
have a biphasic developmental cycle [7-9]. In the early 
stages, infectious forms called elementary bodies (EBs) 
enter mucosal cells and reside in membrane-bound vacu-
oles called inclusions. Within a few hours, the EBs differen-
tiate into larger, metabolically active reticulate bodies 
(RBs) which are non-infectious. After several rounds of 
replication, RBs differentiate back into EBs and are re-
leased from the host cell, ready to infect neighboring cells. 
The cells infected by Chlamydia include epithelial cells, 
smooth muscle cells, fibroblasts, osteoblasts, mono-
cytes/macrophages and dendritic cells [10-13]. These sus-
ceptible host cells recognize chlamydial antigens by several 
means: through cell surface receptors, endosomal recep-
tors, and cytosolic innate immune sensors [10]. Activation 
of these receptors leads to the release of pro-inflammatory 
cytokines and chemokines which recruit inflammatory cells 
to eliminate the infectious agent. Under immunopathologic 
conditions, such as with chronic immune activation, these 
events can lead to tissue damage and scarring. 
The two major chlamydial species that are pathogenic 
to humans are Chlamydia trachomatis and Chlamydia 
pneumoniae [14]. Infection with C. trachomatis can lead to 
non-congenital blindness and genital tract infections and 
complications such as pelvic inflammatory disease, infertili-
ty, ectopic pregnancy, urethritis and cervical cancer. 
C. pneumoniae causes respiratory infections including 
pneumonia, bronchitis, pharyngitis and sinusitis. Approxi-
mately 10% of community-acquired pneumonia cases are 
caused by C. pneumoniae infection [15]. C. pneumoniae has 
also been linked to asthma, arthritis, atherosclerosis, 
stroke, multiple sclerosis and Alzheimer’s disease [12, 15-
18]. Chlamydial infections are treatable with antibiotics, 
but no vaccines are available for prevention. 
C. pneumoniae has not been traditionally considered a 
member of the human oral microbiome and was not 
thought to infect oral cells [2, 19, 20]. However, Rizzo et al. 
reported infecting human gingival fibroblasts in vitro and 
eliciting secretion of the cytokines, interleukin-6 and inter-
leukin-10 [21, 22]. In another study, C. pneumoniae was 
found in the gingival crevicular fluid of one periodontitis 
patient with characteristics similar to a clinical strain [23]. 
Moreover, a characterization of subgingival dental plaque 
revealed that C. pneumoniae was present in one out of 
twelve clinical samples obtained from periodontitis pa-
tients [24]. Unfortunately, in these studies, the clinical 
sample sizes were small and no comparisons to healthy 
patient controls were made. In addition, no demonstration 
had been made that C. pneumoniae can invade the oral 
epithelium, one of the first and major barriers to oral dis-
ease. Currently, it is still not known whether C. pneumoni-
ae infects gingival epithelium and subsequently promotes a 
host-mediated immune response that leads to periodonti-
tis. 
In this study, using 80 dental plaque samples, we ex-
amined whether C. pneumoniae can be found in subgingi-
val dental plaque and whether its presence correlated with 
periodontal disease. In addition, we examined the ability of 
C. pneumoniae to invade gingival epithelial cells and elicit a 
host inflammatory response. 
 
RESULTS 
C. pneumoniae is more frequent in subgingival plaque 
from patients with periodontal disease than in healthy 
controls 
Eighty subgingival dental plaque samples were obtained 
from 20 subjects with and without periodontal disease. In 
the healthy group, subgingival plaque samples were ob-
tained from four periodontally “healthy sites”. In patients 
with periodontitis, subgingival plaque samples were ob-
TABLE 1. Demographic characteristics (mean and SD) of subjects in the Healthy and Disease groups (N = 20). 
 
Variable Healthy Group (n = 10) Disease Group (n = 10) 
Age  36.9 ± 10.8 years 40.5 ±11.6 years 
Sex Female 6 4 
 Male 4 6 
Race White 6 3 
 Asian 3 2 
 Hispanic 1 4 
 African American 0 1 
Education Level High School 2 5 
 Colllege/Postgraduate 8 5 
 
* Individuals with current or past history of smoking were not included in the study. No statistical difference was observed between the 
two groups. 
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tained from both “healthy sites” and “periodontitis sites” 
(two healthy sites and two diseased sites per periodontitis 
patient). The demographic characteristics of the studied 
population are presented in Table 1; no statistically signifi-
cant differences were observed among groups. Table 2 
shows the clinical characteristics for our study population. 
In the periodontitis group, diseased sites exhibited general-
ized moderate chronic periodontitis. 
After extracting total nucleic acids from the dental 
plaque samples, conventional PCR was performed to am-
plify the gene encoding C. pneumoniae 16S rRNA and the 
resultant PCR products were separated on an agarose gel 
(Fig. 1A). In our sample population, we found that 
C. pneumoniae was significantly more frequent in the dis-
eased group compared with the healthy group (Fig. 1B). 
Because C. trachomatis was previously reported in the oral 
cavity of patients with periodontitis [25], we tested the 
specificity of our primers using control samples of 
C. pneumoniae and C. trachomatis and found that our 
C. pneumoniae 16s rRNA primer was specific only for the 
C. pneumoniae species (Supplementary Figure S1). We also 
screened the same samples for two well-known periodon-
tal pathogens: P. gingivalis and A. actinomycetemcomitans 
[3]. As expected, we detected significantly higher levels of 
P. gingivalis (Fig. 1C and D) and A. actinomycetemcomitans 
(Fig. 1E and F) 16S rRNA gene by PCR in diseased samples 
compared with the control groups. Therefore, in our sam-
ple population, the presence of C. pneumoniae, P. gingi-
valis and A. actinomycetemcomitans in dental plaque from 
periodontally diseased sites was significantly more com-
mon than in healthy sites. 
 
C. pneumoniae infects human gingival epithelial cells in 
vitro  
Since our clinical data showed higher levels of C. pneu-
moniae in dental plaque from periodontal disease patients 
compared with controls, we next investigated a possible 
mechanism that could contribute to development of in-
flammation and periodontitis due to C. pneumoniae. Thus, 
we first determined whether C. pneumoniae can infect 
human gingival epithelial cells (GECs). These cells were 
chosen because they are in intimate contact with bacteria 
present in subgingival plaques and they represent the first 
barrier against foreign invasion in the oral cavity. Figure 2A 
shows GECs that were incubated with C. pneumoniae at a 
MOI (multiplicities of infection) of 5 for 4 days. By immuno-
fluorescence microscopy, the fluorescein isothiocyanate-
stained bacterial RBs can be clearly observed inside the 
inclusions within the epithelial cells.   
C. pneumoniae is known to infect human epithelial cells 
from different tissue types with varying degrees of effi-
ciency. These different tissue types include the lung, larynx 
and cervix [26-28]. In Figure 2B, the efficiency of C. pneu-
moniae infection of GECs was compared with infection of 
A549 human lung epithelial cells and HeLa human cervical 
epithelial cells. Using different MOI, C. pneumoniae could 
invade and replicate in GECs to a comparable extent as in 
the cells most often used to study chlamydial infection: 
HeLa cells and A549 cells. While examining the kinetics of C. 
pneumoniae infection of GECs, peak levels of infection 
were seen between days 2 and 4 post-infection. After day 
4, intracellular C. pneumoniae levels began to drop. These 
kinetics are similar to what had been previously reported 
for the infection of HeLa cells by C. pneumoniae [29].  
 
C. pneumoniae infection of GECs causes activation of NF-
κB  
The pro-inflammatory transcription factor NF-κB is one of 
the key regulators of genes involved in the immune and 
inflammatory response. Therefore, we looked at its activa-
tion in GECs infected with C. pneumoniae. GECs incubated 
with C. pneumoniae for three days at a MOI of 5 showed 
nuclear NF-κB/p65 staining, compared with uninfected 
cells, where NF-κB was in the cytosol (Fig. 3). The translo-
cation of NF-κB/p65 from the cytosol to the nucleus indi-
cates activation of this transcription factor. 
 
Infected GECs secrete IL-1β and activated caspase-1 
One of the genes turned on by NF-κB is il-1β (interleukin-
1β). The il-1β gene is first expressed as a precursor protein, 
pro-IL-1β, which is subsequently cleaved by the protease 
caspase-1 to become the mature form, IL-1β protein. Se-
creted IL-1β promotes and amplifies the inflammatory re-
sponse. We therefore examined whether activation of 
NF-κB in GECs infected by C. pneumoniae also results in 
increased secretion of IL-1β cytokine. Over a period of 1 – 5 
days, we found that IL-1β secretion increased steadily over 
time, peaking at 4 days post-infection (Fig. 4A). After four 
days, secreted IL-1β protein began to decline, correlating 
approximately with the time course of C. pneumoniae in-
fection. Not surprisingly, the kinetics of IL-1β secretion also 
TABLE 2. Clinical measurements of healthy and diseased sites. 
 
 Healthy Sites 
(n = 60) 
Diseased Sites 
(n = 20) 
Plaque Index  0.51 + 0.23 1.83 + 0.71 
Gingival Index  0 1.44 + 0.32 
Probing Depth 
(mm) 
1.5 + 0.17 5.75 + 0.97 
Attachment Loss 
(mm) 
0.5 + 0.11 4.25 +1.71 
 
Plaque Index, as defined by the Silness and Loe method [54]: 0 
= no plaque; 1 = light plaque; 2 = moderate plaque; 3 = heavy 
plaque. 
Gingival Index, as defined by the Loe and Silness method [55]:   
0 = no inflammation; 1 = mild inflammation; 2 = moderate 
inflammation; 3 = marked inflammation. 
Probing Depth: 3 or less = healthy (no inflammation and no 
tissue loss); >3 = unhealthy (inflammation and/or tissue loss) 
Attachment Loss: 0 = no destruction of periodontal ligament or 
alveolar bone; 1 or greater = tissue destruction (the higher the 
number, the greater the destruction). 
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paralleled the kinetics of caspase-1 activation. Figures 4B 
and 4C show that the amount of 22 kDa active form of 
caspase-1 in cellular supernatants of infected GECs in-
creased over time from 0 to 4 days post-incubation.   
 
The NLRP3 inflammasome participates in caspase-1 acti-
vation 
NF-κB activation also results in upregulation of nlrp3 (NOD-
like receptor family, pyrin domain containing 3; also known 
as cold induced autoinflammatory syndrome 1, cias1). The 
NLRP3 protein is a member of the nucleotide-binding oli-
gomerization domain (NOD), leucine-rich repeat (LRR)-
containing protein family (NLR family). Other members of 
the NLR family include NLRP1, NLRC4, AIM2 and pyrin. To-
gether with the apoptosis-associated speck-like protein 
containing a CARD (ASC, also known as PYCARD) and pro-
caspase-1, NLRs form the oligomeric signaling platform 
called inflammasome [30, 31]. One of the biochemical 
functions of the inflammasomes is to activate caspase-1.   
Since C. pneumoniae infection of GECs caused activa-
tion of caspase-1 (Fig. 4B), we investigated if an inflam-
masome may be responsible for this activity. The NLRP3 
inflammasome was viewed as a likely candidate since ear-
lier studies showed that treatment with the danger signal, 
extracellular ATP, and infection with the periodontal path-
ogen Fusobacterium nucleatum could activate the NLRP3 
inflammasome in GECs [32-36]. To determine whether the 
NLRP3 inflammasome was involved in caspase-1 activation 
during C. pneumoniae infection, we inhibited nlrp3 expres-
sion in GECs using specific shRNAs packaged into lentiviral 
particles. Figure 5A shows that nlrp3 mRNA expression in 
the lentivirus-transduced cells was roughly half of that 
seen in non-transduced cells or cells transduced with irrel-
evant shRNA control. The decrease in nlrp3 gene expres-
sion in GECs also showed a corresponding decrease in 
caspase-1 activation during infection, as seen in Figure 5B 
and C. The data therefore indicate that the NLRP3 inflam-
masome is involved in the proteolytic cleavage and activa-
tion of caspase-1 during C. pneumoniae infection of GECs. 
FIGURE 1: C. pneumoniae is present more frequently in subgingival plaque obtained from periodontally diseased sites vs. healthy sites. 
Dental plaques were obtained from subgingival locations in ten healthy patients (HPt, four sites for each one) and in ten patients with peri-
odontal disease (PPt). For patients with periodontal disease, subgingival dental plaques were obtained from both areas with periodontitis 
(P, two sites per subject) and areas without periodontitis (H, two sites per subject). All dental plaque samples were subjected to PCR fol-
lowed by agarose gel electrophoresis. (A, C, E) Representative gel electrophoretogram of PCR products screening C. pneumoniae (A), P. 
gingivalis (C) and A. actinomycetemcomitans (E). Quantification of C. pneumoniae (B), P. gingivalis (D) and A. actinomycetemcomitans (F) 
16S rRNA, PCR products. (B, D, F) Healthy sites: n = 40 (only from healthy donors) and diseased sites: n = 20. For each dental plaque sample, 
seven different runs were performed for C. pneumoniae and three different runs for P. gingivalis and A. actinomycetemcomitans. Arrows 
indicate positive bands in the expected bp size. Error bars represent ± SD; 2-sided, paired Student’s t test, *P < 0.05, ***P<0.001. 
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DISCUSSION 
The human oral microbiome consists of over 600 abundant 
species of bacteria, of which fewer than a dozen have been 
associated with periodontal disease [2, 37, 38]. Although 
there are recent data to suggest C. pneumoniae may be 
part of the oral microbiota and may play a role in perio-
dontitis, the data are scant and incomplete. Moreover, 
C. pneumoniae has never been shown to interact with the 
gingival epithelium. In the present study, we studied a 
large number of clinical samples along with healthy patient 
controls and used human GECs as a relevant in vitro model 
to investigate C. pneumoniae infection of oral tissue. 
In this study we used 80 subgingival dental plaques ob-
tained from patients with and without periodontitis and 
showed higher levels of C. pneumoniae in diseased sites 
compared with control sites. P. gingivalis and A. actinomy-
cetemcomitans, two well-known periodontopathogens, 
were also found in higher levels in diseased sites compared 
to controls. To the best of our knowledge, this is the first 
time that C. pneumoniae and other periodontopathogens 
are found in the same dental plaque samples. Moreover, it 
is not known how or whether C. pneumoniae can contrib-
ute to the development of periodontitis. In this context, 
our study showed for the first time the presence of 
C. pneumoniae in dental plaques more often in periodonti-
tis samples and in healthy sites, comparing healthy and 
diseased groups (80 sites from 20 patients). To confirm our 
initial observations, future studies will use a larger sample 
population in order to establish a correlation between the 
disease and the presence of C. pneumoniae; analyze IgG 
and IgM antibodies against C. pneumoniae in blood sam-
ples from the same population of patients; and examine 
whether viable C. pneumoniae can be recovered from den-
tal plaque samples. Additionally, we did not observe differ-
ences between the groups regarding sex, race and educa-
tion levels (Table 1), probably because of our small size 
population.  
In this study, we used human GECs as an in vitro model 
to examine C. pneumoniae invasion of the oral epithelium 
and induction of host inflammation. We found that C. 
pneumoniae can infect human GECs, with maximal growth 
and replication within inclusions inside the host after four 
FIGURE 2: C. pneumoniae infects human gingival epithelial cells. (A). Gingival epithelial cells (GECs), infected four days with C. pneumoniae 
at MOI of 5, were incubated with a FITC-conjugated mAb against Chlamydia (green) for 15 minutes, and the nuclei were counterstained 
with Hoechst (blue). (B) qPCR of hGECs, HeLa cells, and A549 cells infected with C. pneumoniae for two days at MOI of 0, 2 and 5. qPCR 
assays were performed in triplicate, n = 4 independent experiments. Error bars represent ± SD; 2-sided, paired Student’s t test, ***P < 
0.001. (C) GECs were infected with C. pneumoniae at MOI of 5 and infected samples were collected 1, 2, 3, 4 and 5 days post-infection for 
qPCR analysis. Assays were performed in triplicates, n = 5 independent experiments. Error bars represent ± SD; 2-sided, paired Student’s t 
test, ***P < 0.001. 
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days post-incubation. This developmental growth pattern 
is similar to what has been reported for infection of cervi-
cal epithelial (HeLa) cells [29], which until now have been 
the main cell type used for studies of C. pneumoniae infec-
tion. Our findings that C. pneumoniae infection caused NF-
κB nuclear translocation and upregulation of IL-1β in GECs, 
in large part through the involvement of the NLRP3 in-
flammasome and subsequent activation of caspase-1, are 
also consistent with findings using other cell types. For 
instance, C. pneumoniae infection of smooth muscle cells, 
monocytes/macrophages, dendritic cells, as well as epithe-
lial cells from non-oral tissues has been reported to result 
in NF-κB activation and upregulation of proinflammatory 
cytokines, including IL-1β [39-43]. Activation of the NLRP3 
inflammasome and caspase-1 has been documented in 
macrophages for C. pneumoniae [44, 45] and in cervical 
epithelial cells for C. trachomatis [46].  
IL-1β is a major player in the periodontal inflammatory 
process underlying chronic periodontitis [47]. In addition, 
oral pathogens are known to activate NF-κB in epithelial 
cells and macrophages [48]; and periodontopathogens 
such as P. gingivalis and F. nucleatum activate NF-κB in 
epithelial cells and increase expression of proinflammatory 
gene transcripts [35, 36, 49, 50]. Thus, we hypothesize that, 
upon C. pneumoniae infection, epithelial cells, macrophag-
es and fibroblasts in the periodontium may secrete pro-
inflammatory cytokines involved in the pathogenesis of 
periodontal disease.  
Although our results show that there are higher levels 
of C. pneumoniae in dental plaque samples with periodon-
tal disease compared with healthy control groups, and the 
results with infected GECs suggest how C. pneumoniae 
could contribute to inflammation in the oral cavity, our 
findings on C. pneumoniae organisms in subgingival dental 
plaques of periodontitis patients do not prove that the 
bacteria cause disease or whether, instead, periodontal 
disease favors their accumulation in dental plaque. Consid-
ering that periodontitis is a polymicrobial disease caused 
by complex interactions between distinct pathogens [37, 
38, 51], it is possible that other microbial agents present in 
the dental plaques of periodontitis patients could be the 
cause of disease, and C. pneumoniae could simply be modi-
fying the composition of the microbial community in dental 
plaques. Future studies will need to examine the interac-
tion of other pathogenic microorganisms in dental plaques 
with C. pneumoniae to determine how they elicit a host 
FIGURE 3: Activation of NF-κB in hGECs infected with C. pneumoniae. hGECs were infected with C. pneumoniae at a MOI of 5 for three 
days and immunocytochemistry performed using a NF-κB/p65 monoclonal antibody (red). hGEC cell nuclei were counterstained with 
Hoechst (blue).  
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inflammatory response and subsequent development of 
periodontitis. 
Moreover, it is not known whether the C. pneumoniae 
in subgingival dental plaques is infectious in the oral cavity; 
or whether C. pneumoniae in dental plaques could behave 
as a reservoir for the pathogen that could lead to lung in-
fections. Additionally, the gingival epithelium has stratified 
squamous keratinized cells and most studies so far, includ-
ing our own, analyzed chlamydial infection in monolayer 
cell models of infection. Even though C. pneumoniae has 
never been reported to be present in the human gingival 
epithelium, a recent study showing that C. trachomatis 
infects three-dimensional organotypic stratified squamous 
epithelial cultures [52] suggests that similar events may 
occur in the oral cavity. Finally, an oral reservoir of 
C. pneumoniae could infect circulating immune cells and 
thus contribute to other inflammatory diseases. This could 
conceivably be the case for atherosclerosis, since individu-
als with periodontitis are known to be at a higher risk for 
foam cell formation and arteriosclerosis [12, 53]. Clearly, 
more studies are needed to elucidate the role of C. pneu-
moniae in the mouth and systemic diseases, which should 
lead to a better understanding of the pathogenesis of peri-
odontal disease in relation to systemic diseases in general. 
 
MATERIALS AND METHODS 
Clinical subjects and samples 
The study population consisted of 20 medically healthy sub-
jects with an average of 38.7 + 11.2 years (range 26.8 to 62.3) 
and included ten women and ten men. Ten subjects were in 
the disease group (two periodontitis sites and two healthy 
sites for each participant were the study sites collected), and 
ten subjects were in the periodontally healthy group (four 
healthy sites for each subject were the study sites). All study 
participants signed a consent form approved by the Institu-
tional Review Board of University of the Pacific. Exclusion cri-
teria for participants included the following: individuals who 
were younger than 25 years of age, who did not have at least 
two none adjacent periodontitis sites and two healthy sites in 
the disease group, and four healthy sites in the healthy group 
(excluding third molars), who did not have 20 teeth, who re-
quired premedication with antibiotics prior to periodontal 
exam, who had taken antibiotics or anti-inflammatory drugs 
within the last six months, or gone through periodontal thera-
py within the last six months, or who are current or past 
smokers.      
FIGURE 4: C. pneumoniae infection activates caspase-1 and IL-1β release. Equal numbers of GECs were infected with C. pneumoniae and 
cultured in equal volumes of medium for five days in (A) and four days in (B, C) at a MOI of 5. At 0, 1, 2, 3, 4 and 5 days post-infection, 
supernatants were collected and analyzed for the presence of mature IL-1β or activated caspase-1 protein. (A) IL-1β ELISA. Assays were 
performed in triplicates, n = 3 independent experiments. (B) Western blot representative gel and (C) quantification of active caspase-1 
proteins. Three independent experiments were performed. For panels A and C: error bars represent ± SD; 2-sided, paired Student’s t test, 
***P < 0.001. 
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Study design 
A single calibrated examiner performed all clinical measure-
ments and plaque sampling. Clinical measurements including 
plaque index [54], gingival index [55], bleeding on probing, 
duplicate measurements of probing depth and attachment 
loss were recorded in 20 periodontitis sites and 60 healthy 
sites using a North Carolina probe.  
The criteria for healthy sites and periodontitis sites were 
as follows. Healthy sites (including sites with gingival reces-
sion) were defined as: Gingival index = 0; probing depth < 4 
mm; attachment loss < 3 mm. For periodontitis sites: Gingival 
index > 0; probing depth > 4 mm; attachment loss > 3 mm. 
 
Plaque collection and qPCR analysis of clinical samples 
Using sterile Gracey curettes, subgingival dental plaques were 
obtained from consenting patients, and stored in a -80°C 
freezer until the day of analysis. A total of 80 subgingival 
plaque samples were collected from the participants in dis-
eased and healthy study groups.  
The plaque from the curette was resuspended in 350 µl of 
RTF buffer (0.045% K2HPO4, 0.09% NaCl, 0.09% (NH4)2SO4, 
FIGURE 5: Inhibition of nlrp3 gene expression re-
duces caspase-1 activation. (A) qPCR for nlrp3 gene 
expression was performed using RNA extracted 
from GECs transduced with lentiviruses carrying 
shRNAs targeting nlrp3 (nlrp3 shRNA) or non-
targeting control shRNAs (ctl shRNA). qPCR assays 
were performed in triplicates, n = 4 independent 
experiments. Error bars represent ± SD; 2-sided, 
paired Student’s t test, **P < 0.01. (B) Western blot 
representative image and (C) quantification of 
caspase-1 of supernatants from lentivirus-
transduced GECs. Three independent experiments 
were performed; a representative blot is shown. 
Error bars represent ± SD; 2-sided, paired Student’s 
t test, ***P < 0.001. 
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0.018% MgSO4, 0.038% EDTA, 0.04% Na2CO3, 0.02% dithio-
threitol) [56]. Samples were boiled at 96°C for 10 min and 
centrifuged, and supernatants were collected for nucleic acids 
analysis.  
PCR was performed to amplify the 16S rRNA gene of C. 
pneumoniae, C. trachomatis, P. gingivalis and 
A. actinomycetemcomitans using the Fast Cycling PCR Kit (Qi-
agen, Valencia, CA, USA). A hot-start protocol was used at 
95°C (5 min) and the PCR cycling parameters were: denatura-
tion at 96°C (5 sec), annealing at 45°C (5 sec) for C. pneumoni-
ae, 57°C (5 sec) for C. trachomatis, 52°C (5 sec) for P. gingivalis 
and A. actinomycetemcomitans, and extension at 68°C (15 sec) 
for C. pneumoniae, 68°C (9 sec) for C. trachomatis and 68°C (4 
sec) for P. gingivalis and A. actinomycetemcomitans in a total 
of 40 cycles, followed by a final extension at 72°C (1 min). 
Primer sets, final concentration and amplicon size were as 
follows for the different pathogens: C. pneumoniae 16S rRNA 
Forward 5’-TGACAACTGTAGAAATACAGC-3’, C. pneumoniae 
16S ribosomal RNA Reverse 5’- CGCCTCTCTCCTATAAAT-3’ [57], 
both primers were used at 0.4 µM final concentration result-
ing in a 465-bp amplicon; C. trachomatis 16S rRNA Forward 5’-
GGCGTATTTGGGCATCCGAGTAACG-3’, C. trachomatis 16S 
rRNA Reverse 5’-TCAAATCCAGCGGGTATTAACCGCCT-3’ [58], 
both primers were used at 0.3 µM final concentration, result-
ing in a 315-bp amplicon; P. gingivalis 16S rRNA Forward 
5’-TGTAGATGACTGATGGTGAAAACC-3’, P. gingivalis 16S rRNA 
Reverse 5’-ACGTCATCCCCACCTTCCTC-3’ [59], both primers 
were used at 0.3 µM final concentration, resulting in a 198-bp 
amplicon; A. actinomycetemcomitans 16S rRNA Forward 5’-
ATTGGGGTTTAGCCCTGGTG-3’, A. actinomycetemcomitans 16S 
rRNA Reverse 5’-ACGTCATCCCCACCTTCCTC-3’ [59], both pri-
mers were used at 0.5 µM final concentration, resulting in a 
360-bp amplicon. All amplicon sizes were examined by elec-
trophoresis in a 2% agarose gel stained with a final concentra-
tion of 0.5 µg/ml ethidium bromide (EtBr; Invitrogen, Carlsbad, 
CA) and visualized under UV light. To be used as positive con-
trols, genomic DNA was isolated from C. pneumoniae (CM-1, 
ATCC and ATCC VR-1360D, Chlamydophila pneumoniae, Strain 
CM-1), P. gingivalis (ATCC® 33277), A. actinomycetemcomitans 
(ATCC® 29522) using TRIzol (Thermo Fisher Scientific), and DNA 
of C. trachomatis was obtained from ATCC (ATCC® VR-885D, 
Serovar D; Strain UW-3/Cx). Ultra-pure water was used as 
negative control indicating primers were specific without self-
annealing detections. 
The scoring of the electrophoretograms was done by two 
different individuals with double-blinded samples. Neither the 
status of the donor (healthy patient vs. periodontitis patient) 
nor the status of the subgingival location (healthy site vs. dis-
eased site) were known to the scorers. Samples were scored 
as “positive” if the ethidium bromide-stained gel band corre-
sponding to the different bacteria, at the expected size, was 
visible to the scorer’s naked eye. 
 
Mammalian cell culture 
Human immortalized gingival epithelial cells (GECs) were pre-
viously described [35]. GECs were cultured in 1X defined 
Keratinocyte Serum-Free Medium (KSFM: Gibco Life Technol-
ogies, Gaithersburg, MD, USA) supplemented with 30 µg/ml 
bovine pituitary extract (Gibco Life Technologies), and 
0.2 ng/ml of human recombinant epidermal growth factor 
(Gibco Life technologies) at 37°C, 5% CO2. 
Human cervical epithelial cells, HeLa, were obtained from 
ATCC® (CCL-2™) and cultured in Minimum Essential Medium 
(Gibco Life Technologies) supplemented with 10% FBS (Invi-
trogen) at 37°C, 5% CO2, as previously described [46]. Human 
lung epithelial cells, A549, were obtained from ATCC® (CCL-
185™) and cultured in F-12 medium (Gibco Life Technologies) 
supplemented with 10% FBS at 37°C, 5% CO2. 
 
Infection of GECs with C. pneumoniae 
C. pneumoniae (CM-1, ATCC, Manassa, VA) was grown and 
quantified as previously described [60, 61].   
GECs were seeded on 18 mm glass cover slips (Fisher Sci-
entific, Hampton, NH, USA) or 6-well plates (Corning, Corning, 
NY, USA) and grown to 60% confluency, after which C. pneu-
moniae bacteria were added at various multiplicity of infection 
(MOI) and incubated for various lengths of time as indicated in 
the figure legends.   
 
C. pneumoniae immunofluorescence    
GECs were grown on 18 mm glass coverslips and infected with 
C. pneumoniae at a MOI of 5. After four days, supernatants 
were aspirated, and the C. pneumoniae-infected cells fixed 
with freezing cold methanol for 10 minutes. The cells were 
then washed three times with 1X phosphate-buffered saline 
(PBS), permeabilized with 0.1% Triton X-100 in PBS for 
15 minutes and blocked with 5% bovine serum albumin (BSA: 
Sigma Aldrich St. Louis, MO, USA) in PBS for 1 hour. To visual-
ize C. pneumoniae in the GECs, infected cells were incubated 
with a fluorescein isothiocyanate (FITC)-conjugated monoclo-
nal antibody from the IMAGEN™ Chlamydia Kit (Invitrogen) 
following manufacturer’s instructions. Cell nuclei were coun-
terstained with 2 µg/ml Hoechst 33342 (Sigma-Aldrich, St. 
Louis, MO, USA). Fluorescence images were captured using a 
DMI4000B confocal microscope (Leica, Deerfield, IL, USA) and 
analyzed using LAS-AF software (Leica). 
 
NF-κB/p65 immunofluorescence 
GECs were grown on 18 mm glass coverslips and infected with 
C. pneumoniae at a MOI of 5. After three days, the cells were 
washed, fixed with 4% paraformaldehyde, and permeabilized 
with 0.1% Triton X-100 in PBS for 40 minutes. Following one 
wash with PBST (0.05% Tween-20 in PBS) and two washes with 
PBS, the cells were blocked with 2% BSA in PBS for 30 minutes 
before hybridization overnight at 4°C with a rabbit monoclonal 
antibody against NF-κB/p65 (Cell Signaling, catalog #8242). 
Cells were again washed once with PBST followed by two PBS 
washes before incubation with Alexa Fluor 546-conjugated 
goat anti-rabbit IgG (Invitrogen) for 40 minutes. Cell nuclei 
were counterstained with 2 µg/ml Hoechst 33342 (Sigma-
Aldrich). Fluorescence images were captured using a 
DMI4000B confocal microscope (Leica) and analyzed using 
LAS-AF software (Leica). 
 
Quantitative real-time PCR 
GECs, HeLa cells and A549 cells were grown in 6-well plates 
and infected with C. pneumoniae at indicated MOI and times 
as shown in the figure legends. Total RNA was extracted from 
the infected cells using TRIzol following manufacturer’s in-
structions (Invitrogen) and nucleic acid concentration was 
determined using a NanoDrop instrument (ThermoScientific 
Life Sciences, Rockford, IL, USA). cDNAs were synthesized from 
2 µg RNA using random hexamers and reagents from the 
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Taqman Reverse Transcription Reagents Kit (Applied Biosys-
tems, Foster City, CA, USA). Using 1:50 of the prepared cDNA, 
sense and antisense primers, Mx300P (Stratagene, La Jolla, CA, 
USA) and Brilliant QPCR Master Mix (Stratagene) in a total 
reaction volume of 25 µL, quantitative PCR was performed 
with the following thermocycler settings: 95°C for 10 minutes, 
followed by 40 cycles at 95°C for 30 seconds, 55°C for 1 mi-
nute, and 72°C for 30 seconds. C. pneumoniae 16S rRNA gene 
expression was normalized to GAPDH through comparative 
cycle threshold method. The primers used for C. pneumoniae 
16S rRNA were: 5’-TTATTAATTGATGGTACAATA-3’ and 
5’-ATCTACGGCAGTAGTATAGTT-3’. The primers used for 
GAPDH were 5’-CTTCTCTGATGAGGCCCAAG-3’ and 
5’-GCAGCAAACTGGAAAGGAAG-3’. 
 
IL-1β ELISA 
GECs were seeded into 6-well plates (Corning) and grown to 
60% confluency, after which C. pneumoniae bacteria were 
added at a MOI of 5. Supernatants were collected at 0, 1, 2, 3 
and 4 days post-infection, centrifuged at 800 x g for 5 minutes 
to remove cellular debris, and stored at -80°C until ELISA anal-
ysis. Measurement of secreted IL-1β proteins was carried out 
using a human IL-1β ELISA Kit (eBioscience, San Diego, CA, 
USA) following the manufacturer’s instructions. 
 
Caspase -1 Western blot  
A total of 750,000 cells were seeded into each well of 6-well 
plates (Corning). C. pneumoniae was added to the cells at a 
MOI of 5. Supernatants were collected from uninfected cells 
(day 0 post-infection) and from infected cells at 1, 2, 3, and 4 
days post-infection. All supernatants were centrifuged to re-
move cellular debris and then subjected to trichloroacetic acid 
(TCA) precipitation to concentrate the proteins [36]. Briefly, 
one volume of 100% TCA was added to four volumes of clari-
fied supernatants and incubated for 10 minutes at 4°C. After 
incubation, samples were centrifuged at 800 x g for 
5 minutes and pellets washed twice with 100% cold acetone. 
Washed pellets were dried by heating at 95°C for 5-10 minutes. 
Dried pellets were resuspended in Pierce Lane Marker Reduc-
ing Sample Buffer (Thermo Fisher Scientific Life Sciences, 
Rockford, IL, USA), boiled at 95°C for 5 minutes, and loaded 
onto 12% SDS-polyacrylamide gels. After performance of SDS-
PAGE, separated proteins were transferred to polyvinylidene 
difluoride membranes (PVDF membranes: EMD Millipore, 
Darmstadt, Germany). The membranes were blocked with 5% 
BSA (Sigma-Aldrich) for 1 hour at room temperature (RT), and 
then incubated with 1 mg/ml rabbit anti-human caspase-1 
polyclonal antibodies (EMD Millipore) overnight at 4°C. The 
next day, the membranes were washed and incubated for 
1 hour at RT with HRP-conjugated anti-rabbit secondary anti-
bodies diluted 1:10,000 (EMD Millipore). The membranes 
were washed again, and the proteins were visualized using the 
ECL Plus Western blot substrate (Amersham Biosciences, Little 
Chalfont, UK). Chemiluminescent images were acquired using 
the ChemiDoc XRS+ system (Bio-Rad, Hercules, CA, USA) and 
analyzed using the ImageJ software. 
 
NLRP3-deficient GECs 
Immortalized GECs stably expressing shRNA against NLRP3 
(NCBI accession no: NM_004895, sequence 
5’– CCGGGCGTTAGAAACACTTCAAGAACTCGAGTTCTTGAAGTG- 
TTTCTACGCTTTTTG-3’) were generated by transducing the 
cells with lentiviral particles (Sigma- Aldrich, St. Louis, MO). 
Transduction was performed according to manufacturer’s 
instructions. Non-target shRNA control was also generated 
using an irrelevant sequence (NCBI accession no: SHC002; 
sequence 5’-GGCAACAAGATGAAGAGCACCAACTCGA-
GTTGGTGCTCTTCATCTTGTTGTTTTT–3’). Briefly, GECs were 
plated at 35% confluency and grown for 24 hours, after which 
the corresponding lentiviral transduction particles were added 
at a MOI of 5 in OPTIMEM medium (Gibco Life Technologies). 
After 24 hours incubation, stably-infected cells were selected 
using fresh medium containing 2 μg/ml puromycin (Sigma-
Aldrich). The knockdown efficiency was tested by real-time 
PCR as indicated above. mRNAs were isolated from trans-
duced and non-transduced cells using the Qiagen RNeasy Kit 
(Qiagen) following the manufacturer’s instructions. 
 
Statistical analysis 
When comparing two groups, two-tailed t-test was used. The 
significance of differences among groups for age was assessed 
by t-test. Fisher’s exact test was used to compare groups re-
garding sex and education level. Chi square was used to com-
pare the differences in the frequency of different races be-
tween the groups. The statistical analysis was performed with 
Graph Pad Prism v. 5 software. Statistical differences were 
shown as asterisks, where: ***p<0.001, **p<0.01, *p<0.05. 
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